Related Experiment Videos
Model-predictive control of hyperthermia treatments
Dhiraj Arora1, Mikhail Skliar, Robert B Roemer
1Department of Mechanical Engineering, University of Utah, Salt Lake City 84112, USA.
IEEE Transactions on Bio-Medical Engineering
|June 27, 2002
Summary
A novel model-predictive controller (MPC) precisely regulates thermal dose during hyperthermia cancer treatment. This feedback control system ensures safety by managing temperatures in normal tissues while targeting tumors effectively.
Area of Science:
- Biomedical Engineering
- Control Systems
- Oncology
Background:
- Hyperthermia cancer treatment aims to elevate tumor temperature.
- Controlling thermal dose precisely is crucial for efficacy and safety.
- Existing methods often control temperature, not the cumulative thermal dose.
Purpose of the Study:
- To develop and evaluate a model-predictive controller (MPC) for direct thermal dose control in hyperthermia.
- To investigate the first application of feedback control to pulsed, high-temperature hyperthermia.
- To assess MPC's capability in managing thermal dose and tissue constraints.
Main Methods:
- Developed a model-predictive controller (MPC) for thermal dose regulation.
- Utilized one-point and one-dimensional tumor models for simulations.
- Incorporated varying blood flow rates and normal tissue temperature constraints.
Main Results:
- Demonstrated successful thermal dose control despite model-plant mismatch.
- Showcased MPC's ability to meet normal tissue temperature constraints and power limits.
- Linear MPC performed adequately for limited temperature variations; nonlinear MPC needed for larger variations.
Conclusions:
- MPC offers a viable strategy for precise thermal dose control in hyperthermia.
- The controller effectively manages treatment parameters and ensures safety.
- Future work should focus on nonlinear MPC for broader applicability in hyperthermia treatments.